Meeting
2019 ASCO Annual Meeting
Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic population.
Authors
Mohamad Barakat
UCSF Fresno, Fresno, CA
Mohamad Barakat , Maher Albitar , Robin L. Whitney , Calvin Chen , Yu-Hung Kuo , William Silveira , Mohammed SANI BUKARI , Subramanyeswara Rao Arekapudi , Karamjit Dhaliwal-Binning , Haifaa Abdulhaq
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Non-Hodgkin Lymphoma
Citation
J Clin Oncol 37, 2019 (suppl; abstr 7535)
DOI
10.1200/JCO.2019.37.15_suppl.7535
Abstract #
7535
Poster Bd #
289
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Molecular profiling of primary central nervous system lymphoma as compared to activated B-cell subtype of diffuse large B-cell lymphoma.
First Author: Mohamad Barakat
Poster
2014 ASCO Annual Meeting
Gene expression analysis of B-cell receptors (BCR) pathway for identification of PDE4B gene as potential therapeutic target to overcome glucocorticoid resistance in primary CNS lymphoma.
First Author: Ariz Akhter
Poster
2023 ASCO Annual Meeting
A nationwide population based primary CNS lymphoma (PCNSL) analysis: Do Hispanics have better outcomes?
First Author: Ysaith Orellana
Poster
2017 ASCO Annual Meeting
Phase II study of single-agent copanlisib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
First Author: Georg Lenz